டேனியல் வெள்ளிகள் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from டேனியல் வெள்ளிகள். Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In டேனியல் வெள்ளிகள் Today - Breaking & Trending Today

Leisure Acquisition Corp. Announces Receipt of and Plan to Appeal Nasdaq Listing Determination

/PRNewswire/ Leisure Acquisition Corp. ("LACQ" or the "Company") (Nasdaq: LACQ, LACQU, LACQW), a special purpose acquisition company formed for the purpose. ....

New York , United States , Lorne Weil , Leisure Acquisition Corp , Company Nasdaq , Nasdaq Hearings Panel , Company Form , Exchange Commission , Nasdaq Hearing Panel , Ensysce Biosciences Inc , Prnewswire Leisure Acquisition Corp , Nasdaq Listing Rule , Ensysce Biosciences , Daniel Silvers , Initial Public Offering , Nasdaq Capital Market , Registration Statement , Leisure Acquisition Corp , புதியது யார்க் , ஒன்றுபட்டது மாநிலங்களில் , லார்ன் வெயில் , ஓய்வு கையகப்படுத்தல் கார்ப் , நிறுவனம் நாஸ்டாக் , நாஸ்டாக் விசாரணைகள் குழு , நிறுவனம் வடிவம் , பரிமாற்றம் தரகு ,

Ensysce Biosciences, Inc. And Leisure Acquisition Corp. Announce Appointment Of Dave Humphrey As Chief Financial Officer

Share this article
Share this article
NEW YORK and SAN DIEGO, Feb. 18, 2021 /PRNewswire/ Ensysce Biosciences Inc. ( Ensysce ), a clinical stage pharmaceutical company developing medicines for severe pain relief to reduce fear of addiction, opioid misuse, abuse and overdose, and Leisure Acquisition Corp. (NASDAQ: LACQ) ( LACQ ) today announced the appointment of David Humphrey to Ensysce s management team as its Chief Financial Officer.
Mr. Humphrey brings over 20 years of experience with development-stage companies as they progress toward product commercialization. Prior to joining Ensysce, Mr. Humphrey was Chief Financial Officer of Senomyx, Inc., a publicly-held biotechnology company which he led through an acquisition by Firmenich SA, a private Swiss multinational flavor and fragrance company. As part of his responsibilities, he will oversee financial strategy and business expansion at Ensysce, in addition to assisting with Ensysce s proposed business combina ....

New York , United States , Lorne Weil , Lynn Kirkpatrick , Leisure Acquisition Corp , National Institute On Drug Abuse , National Institutes Of Health , Ensysce Biosciences Inc , Prnewswire Ensysce Biosciences Inc , Senomyx Inc , Leisure Acquisition , David Humphrey , Chief Financial , Chief Financial Officer , National Institutes , National Institute , Drug Abuse , Ensysce Biosciences , Deterrent Formulation , Trypsin Activated Abuse Protection , Multi Pill Abuse Resistance , Daniel Silvers , Initial Public Offering , Nasdaq Capital Market , George Peng , Acquisition Corp ,